
Pharmanet Group granted South African patent
TOP News
Source: News Bites
Pharmanet Group has been granted a South African patent over the use and manufacture of its proprietary active ingredients for analgesic and anti-inflammatory action. The patent was granted to the company's South African subsidiary, Cambridge Scientific.
The new patent is the first in a series of international patent applications relating to the Tripeptofen project, which deals with the analgesic and anti-inflammatory fields.
STOCK DASHBOARD: July 14, 2008
Pharmanet Group
Last traded July 11, 2008: 0.60c
Price change from previous trading day: 50.0%
Relative Strength (6 months percentile rank): 26.2
Market capitalisation: $2 million
Turnover volume: 100,000.0
Volume Index (1 is average): 0.1
Turnover value: $600
Turnover period: 1 year 22 days
Value of $1,000 invested 1 year ago: $261
Source: www.BuySellTips.com
Related Industry SectorsView the latest stories on Health & Pharmaceuticals
Related CompaniesView all stories on PHARMANET GROUP
Earnings Season Results